ACADIA Pharmaceuticals Inc
NASDAQ:ACAD

Watchlist Manager
ACADIA Pharmaceuticals Inc Logo
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD
Watchlist
Price: 27.15 USD 1.76% Market Closed
Market Cap: 4.6B USD

Wall Street
Price Targets

ACAD Price Targets Summary
ACADIA Pharmaceuticals Inc

Wall Street analysts forecast ACAD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACAD is 29.85 USD with a low forecast of 17.17 USD and a high forecast of 40.95 USD.

Lowest
Price Target
17.17 USD
37% Downside
Average
Price Target
29.85 USD
10% Upside
Highest
Price Target
40.95 USD
51% Upside
ACADIA Pharmaceuticals Inc Competitors:
Price Targets
300676
BGI Genomics Co Ltd
31% Upside
PGEN
Precigen Inc
135% Upside
CNTB
Connect Biopharma Holdings Ltd
222% Upside
DVYSR
Devyser Diagnostics AB
41% Upside
GLPG
Galapagos NV
11% Upside
EDT
Spectral Medical Inc
149% Upside
FYB
Formycon AG
116% Upside
SNDX
Syndax Pharmaceuticals Inc
92% Upside

Revenue
Forecast

Revenue Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
ACADIA Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACAD's stock price target?
Price Target
29.85 USD

According to Wall Street analysts, the average 1-year price target for ACAD is 29.85 USD with a low forecast of 17.17 USD and a high forecast of 40.95 USD.

Back to Top